Published online before print October 21, 2002, doi: 10.1161/01.CIR.0000037221.45902.69
(Circulation. 2002;106:2567.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
Analysis of Cardiovascular Phenotype and Genotype-Phenotype Correlation in Individuals With a JAG1 Mutation and/or Alagille Syndrome
From the Divisions of Cardiology (D.B.E., E.G.), Human Genetics (I.D.K., L.B., N.B.S.), and Gastroenterology and Nutrition (D.A.P.), The Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pa, and Division of Gastroenterology (K.M.E.), Children’s Memorial Hospital, Chicago, Ill. Dr McElhinney is now at the Department of Cardiology, Children’s Hospital, Boston, Mass.
Correspondence to Elizabeth Goldmuntz, MD, Division of Cardiology, The Children’s Hospital of Philadelphia, Abramson Research Center 702A, 3516 Civic Center Blvd, Philadelphia, PA 19104-4318. E-mail goldmuntz{at}email.chop.edu
Background— Cardiovascular anomalies are among the most common features of Alagille syndrome (AGS). Mutations of JAG1 are found in most individuals with AGS. This study was undertaken to determine the spectrum of cardiovascular phenotypes associated with a JAG1 mutation and/or AGS, investigate potential genotype-phenotype correlations, and begin to correlate clinical outcome with genetic pathogenesis.
Methods and Results— We reviewed the records of 200 individuals with a JAG1 mutation or AGS. A total of 187 (94%) subjects had evidence of cardiovascular involvement. Cardiovascular anomalies were identified by imaging in 150 subjects (75%), and 37 (19%) had a peripheral pulmonary stenosis murmur with either a normal echocardiogram or no imaging study. Of the 150 subjects with anomalies confirmed by imaging, right-sided anomalies were present in 123 and left-sided anomalies in 22, with both in 12. Seventeen subjects had other anomalies. The most common abnormality was stenosis/hypoplasia of the branch pulmonary arteries (PAs), which was documented by imaging (n=111) or inferred from a peripheral pulmonary stenosis murmur (n=41) in 76% of subjects. Tetralogy of Fallot was present in 23 subjects and was accompanied by pulmonary atresia in 8. Branch PA phenotype differed between individuals with and without a JAG1 mutation. Among subjects with a JAG1 mutation, there was no correlation between the type or location of mutation and the frequency or type of cardiovascular anomaly.
Conclusions— More than 90% of individuals with a JAG1 mutation or AGS have cardiovascular anomalies, with branch PA stenosis the most common abnormality. Cardiovascular phenotype does not correlate with the type or location of JAG1 mutation.
Key Words: cardiovascular disease • genetics • tetralogy of Fallot
This article has been cited by other articles:
 |
|
 |
|
  G. Michielon, B. Marino, G. Oricchio, M. C. Digilio, F. Iorio, S. Filippelli, S. Placidi, and R. M. Di Donato Impact of DEL22q11, trisomy 21, and other genetic syndromes on surgical outcome of conotruncal heart defects J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 565 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Collesi, L. Zentilin, G. Sinagra, and M. Giacca Notch1 signaling stimulates proliferation of immature cardiomyocytes J. Cell Biol., October 6, 2008; 183(1): 117 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Niessen and A. Karsan Notch Signaling in Cardiac Development Circ. Res., May 23, 2008; 102(10): 1169 - 1181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. High, M. M. Lu, W. S. Pear, K. M. Loomes, K. H. Kaestner, and J. A. Epstein Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development PNAS, February 12, 2008; 105(6): 1955 - 1959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Zeltser, G. P. Jarvik, J. Bernbaum, G. Wernovsky, A. S. Nord, M. Gerdes, E. Zackai, R. Clancy, S. C. Nicolson, T. L. Spray, et al. Genetic factors are important determinants of neurodevelopmental outcome after repair of tetralogy of Fallot J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 91 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Roca and R. H. Adams Regulation of vascular morphogenesis by Notch signaling Genes & Dev., October 15, 2007; 21(20): 2511 - 2524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wagner and M. A. Q. Siddiqui Signal Transduction in Early Heart Development (II): Ventricular Chamber Specification, Trabeculation, and Heart Valve Formation Experimental Biology and Medicine, July 1, 2007; 232(7): 866 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Niessen and A. Karsan Notch signaling in the developing cardiovascular system Am J Physiol Cell Physiol, July 1, 2007; 293(1): C1 - C11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Pierpont, C. T. Basson, D. W. Benson Jr, B. D. Gelb, T. M. Giglia, E. Goldmuntz, G. McGee, C. A. Sable, D. Srivastava, and C. L. Webb Genetic Basis for Congenital Heart Defects: Current Knowledge: A Scientific Statement From the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics Circulation, June 12, 2007; 115(23): 3015 - 3038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Hofmann and M. L. Iruela-Arispe Notch Signaling in Blood Vessels: Who Is Talking to Whom About What? Circ. Res., June 8, 2007; 100(11): 1556 - 1568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Blue, J. M. Mah, A. D. Cole, V. Lal, M. J. Wilson, R. B. Chard, G. F. Sholler, R. E. Hawker, M. C. Sherwood, and D. S. Winlaw The negative impact of Alagille syndrome on survival of infants with pulmonary atresia J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1094 - 1096. [Full Text] [PDF]
|
|
|
|
|
|
N. M.S. van den Akker, D. G.M. Molin, P. P.W.M. Peters, S. Maas, L. J. Wisse, R. van Brempt, C. J. van Munsteren, M. M. Bartelings, R. E. Poelmann, P. Carmeliet, et al. Tetralogy of Fallot and Alterations in Vascular Endothelial Growth Factor-A Signaling and Notch Signaling in Mouse Embryos Solely Expressing the VEGF120 Isoform Circ. Res., March 30, 2007; 100(6): 842 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Hovels-Gurich, K. Konrad, D. Skorzenski, C. Nacken, R. Minkenberg, B. J. Messmer, and M.-C. Seghaye Long-Term Neurodevelopmental Outcome and Exercise Capacity After Corrective Surgery for Tetralogy of Fallot or Ventricular Septal Defect in Infancy Ann. Thorac. Surg., March 1, 2006; 81(3): 958 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Michielon, B. Marino, R. Formigari, G. Gargiulo, F. Picchio, M. C. Digilio, S. Anaclerio, G. Oricchio, S. P. Sanders, and R. M. Di Donato Genetic Syndromes and Outcome After Surgical Correction of Tetralogy of Fallot Ann. Thorac. Surg., March 1, 2006; 81(3): 968 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Agarwal, I. Ramnarine, A. F. Corno, and M. Pozzi Recurrent coarctation in a patient with Alagille syndrome Interactive CardioVascular and Thoracic Surgery, December 1, 2005; 4(6): 514 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lorent, S.-Y. Yeo, T. Oda, S. Chandrasekharappa, A. Chitnis, R. P. Matthews, and M. Pack Inhibition of Jagged-mediated Notch signaling disrupts zebrafish biliary development and generates multi-organ defects compatible with an Alagille syndrome phenocopy Development, November 15, 2004; 131(22): 5753 - 5766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Ghez, B. Kreitmann, and D. Metras Reply Ann. Thorac. Surg., November 1, 2004; 78(5): 1886 - 1887. [Full Text] [PDF]
|
|
|
|
|
|
M. Noseda, G. McLean, K. Niessen, L. Chang, I. Pollet, R. Montpetit, R. Shahidi, K. Dorovini-Zis, L. Li, B. Beckstead, et al. Notch Activation Results in Phenotypic and Functional Changes Consistent With Endothelial-to-Mesenchymal Transformation Circ. Res., April 16, 2004; 94(7): 910 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Gridley Notch signaling and inherited disease syndromes Hum. Mol. Genet., April 2, 2003; 12(90001): R9 - 13. [Abstract] [Full Text] [PDF]
|
|